A single centre experience with tocilizumab for steroid-refractory graft-versus-host disease.
Latest Information Update: 21 Oct 2014
At a glance
- Drugs Tocilizumab (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 21 Oct 2014 New trial record